ITLN1 and hepatocellular carcinoma: In addition, ITLN-1 expression was also an independent prognostic factor for DFS, and the DFS rates after hepatectomy were 79.5%, 40.9%, and 20.5% in HCC patients with low expression of ITLN-1, which was significantly lower than the corresponding values of 87.5%, 62.5%, and 36.2% in the group with high expression of ITLN-1 (HR, 0.483; 95% CI, 0.268–0.871; P = .04) (Table 5 and Fig. 5B).